Fishawack adds StoneArch to expanding agency roster
The deal comes on the heels of last week’s purchase of Hive Health.
Most recent articles by John Newton
Five things for pharma marketers to know: Monday, December 28, 2020
Justice Department takes aim at Walmart over opioid prescriptions; vaccine skepticism raises concerns; BMS suspends Opdivo trials in brain cancer.
Five things for pharma marketers to know: Wednesday, December 23, 2020
Texas deviates from CDC vaccination priority guidelines; Answering questions about the new strain of COVID-19; EU approves Pfizer/BioNTech vaccine.
Five things for pharma marketers to know: Tuesday, December 22, 2020
Distribution of Moderna’s COVID-19 vaccine begins; PPE shortages continue; FDA declines to approve Novartis cholesterol drug.
Relevate Health Group and Arteric join forces
The deal creates a 130-strong entity with local market and digital know-how.
The path ahead for the FDA
In a Coalition for Healthcare Communication webinar, former FDA exec Nancy Bradish Myers reflected on the agency’s tumultuous 2020 and charted a path forward for 2021.
Five things for pharma marketers to know: Monday, December 21, 2020
Johnson & Johnson moves forward with COVID vaccine trials; Pence receives vaccine shot on live TV; Merck announces $1 billion collaboration with Janux Therapeutics.
‘Little Lungs’ Anti-Smoking Push Adds Celebrity Muscle
The COVID-era iteration of the campaign warns teens about the consequences of smoking cigarettes.
Five things for pharma marketers to know: Friday, December 18, 2020
FDA committee endorses Moderna’s COVID-19 vaccine; nursing homes begin vaccinating patients; government negotiates with Pfizer to purchase additional vaccine doses.
The Escalator: Ogilvy Health adds Thorn as EVP, head of planning
Plus new hires at CorVista Health, Atkana and Page & Page and Partners.
